Evidence mapPaperPMID 40664818Full record

SynthesisScientific reports2025

Evaluating cognitive decline detection in aging populations with single-channel EEG features based on two studies and meta-analysis.

Lior Molcho, Neta B Maimon, Talya Zeimer, Ofir Chibotero, Sarit Rabinowicz, Vered Armoni, Noa Bar On, Nathan Intrator, Ady Sasson

Abstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lior Molcho *Neurosteer Inc, NYC, New York, USA. lior@neurosteer.com.
Neta B Maimon *Neurosteer Inc, NYC, New York, USA.
Talya ZeimerNeurosteer Inc, NYC, New York, USA.
Ofir ChiboteroNeurosteer Inc, NYC, New York, USA.
Sarit RabinowiczDorot Geriatric Medical Center, Netanya, Israel.
Vered ArmoniDorot Geriatric Medical Center, Netanya, Israel.
Noa Bar OnDorot Geriatric Medical Center, Netanya, Israel.
Nathan IntratorNeurosteer Inc, NYC, New York, USA.
Ady SassonDorot Geriatric Medical Center, Netanya, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely detection of cognitive decline is paramount for effective intervention, prompting researchers to leverage EEG pattern analysis, focusing particularly on cognitive load, to establish reliable markers for early detection and intervention. This comprehensive report presents findings from two studies and a meta-analysis, involving a total of 237 senior participants, aimed at investigating cognitive function in aging populations. In the first study, 80 seniors were classified into two groups: 40 healthy individuals (MMSE > 28) and 40 at risk of cognitive impairment (MMSE 24-27). Dimensionality reduction models, such as Lasso and Elastic Net, were employed to analyze EEG features correlated with MMSE scores. These models achieved a sensitivity of 0.90 and a specificity of 0.57, indicating a robust capability for detecting cognitive decline. The second study involved 77 seniors, divided into three groups: 30 healthy individuals (MMSE > 27), 30 at risk of MCI (MMSE 24-27), and 17 with mild dementia (MMSE < 24). Results demonstrated significant differences between MMSE groups and cognitive load levels, particularly for Gamma band and A0, a novel machine learning biomarker used to assess cognitive states. A meta-analysis, combining data from both studies and additional data, included 237 senior participants and 112 young controls. Significant associations were identified between EEG biomarkers, such as A0 activity, and cognitive assessment scores including MMSE and MoCA, suggesting their potential as reliable indicators for timely detection of cognitive decline. EEG patterns, particularly Gamma band activity, demonstrated promising associations with cognitive load and cognitive decline, highlighting the value of EEG in understanding cognitive function. The study highlights the feasibility of using a single-channel EEG device combined with advanced machine learning models, offering a practical and accessible method for evaluating cognitive function and identifying individuals at risk in various settings.

Indexed as

AgingCognitive DysfunctionElectroencephalographyAgedAged, 80 and overCognitionFemaleHumansMachine LearningMaleMiddle Aged

Identifiers

PMID40664818
PMCPMC12263892

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.